Influence of the lupus anticoagulant on clotting tests
Conclusion The firm diagnosis of a lupus anticoagulant needs the use of multiple test systems including a sensitive screening test, a test to demonstrate that the clotting time prolongation is due to an anticoagulant and a confirmatory test proving the antiphospholipid nature of the anticoagulant. A...
Ausführliche Beschreibung
Autor*in: |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
1990 |
---|
Umfang: |
6 |
---|
Reproduktion: |
Springer Online Journal Archives 1860-2002 |
---|---|
Übergeordnetes Werk: |
in: Clinical rheumatology - 1982, 9(1990) vom: Jan., Seite 45-50 |
Übergeordnetes Werk: |
volume:9 ; year:1990 ; month:01 ; pages:45-50 ; extent:6 |
Links: |
---|
Katalog-ID: |
NLEJ206856970 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLEJ206856970 | ||
003 | DE-627 | ||
005 | 20210706212934.0 | ||
007 | cr uuu---uuuuu | ||
008 | 070528s1990 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)NLEJ206856970 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
245 | 1 | 0 | |a Influence of the lupus anticoagulant on clotting tests |
264 | 1 | |c 1990 | |
300 | |a 6 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Conclusion The firm diagnosis of a lupus anticoagulant needs the use of multiple test systems including a sensitive screening test, a test to demonstrate that the clotting time prolongation is due to an anticoagulant and a confirmatory test proving the antiphospholipid nature of the anticoagulant. A large variety of test systems are currently available for the detection of a lupus anticoagulant. There is a need for further data on the relative sensitivity and specificity of both screening tests and confirmatory methods. | ||
533 | |f Springer Online Journal Archives 1860-2002 | ||
700 | 1 | |a Vermylen, J. |4 oth | |
700 | 1 | |a Arnout, J. |4 oth | |
773 | 0 | 8 | |i in |t Clinical rheumatology |d 1982 |g 9(1990) vom: Jan., Seite 45-50 |w (DE-627)NLEJ188995013 |w (DE-600)1480901-1 |x 1434-9949 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:1990 |g month:01 |g pages:45-50 |g extent:6 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/BF02205551 |
912 | |a GBV_USEFLAG_U | ||
912 | |a ZDB-1-SOJ | ||
912 | |a GBV_NL_ARTICLE | ||
951 | |a AR | ||
952 | |d 9 |j 1990 |c 1 |h 45-50 |g 6 |
matchkey_str |
article:14349949:1990----::nlecoteuuatcauat |
---|---|
hierarchy_sort_str |
1990 |
publishDate |
1990 |
allfields |
(DE-627)NLEJ206856970 DE-627 ger DE-627 rakwb eng Influence of the lupus anticoagulant on clotting tests 1990 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Conclusion The firm diagnosis of a lupus anticoagulant needs the use of multiple test systems including a sensitive screening test, a test to demonstrate that the clotting time prolongation is due to an anticoagulant and a confirmatory test proving the antiphospholipid nature of the anticoagulant. A large variety of test systems are currently available for the detection of a lupus anticoagulant. There is a need for further data on the relative sensitivity and specificity of both screening tests and confirmatory methods. Springer Online Journal Archives 1860-2002 Vermylen, J. oth Arnout, J. oth in Clinical rheumatology 1982 9(1990) vom: Jan., Seite 45-50 (DE-627)NLEJ188995013 (DE-600)1480901-1 1434-9949 nnns volume:9 year:1990 month:01 pages:45-50 extent:6 http://dx.doi.org/10.1007/BF02205551 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 9 1990 1 45-50 6 |
spelling |
(DE-627)NLEJ206856970 DE-627 ger DE-627 rakwb eng Influence of the lupus anticoagulant on clotting tests 1990 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Conclusion The firm diagnosis of a lupus anticoagulant needs the use of multiple test systems including a sensitive screening test, a test to demonstrate that the clotting time prolongation is due to an anticoagulant and a confirmatory test proving the antiphospholipid nature of the anticoagulant. A large variety of test systems are currently available for the detection of a lupus anticoagulant. There is a need for further data on the relative sensitivity and specificity of both screening tests and confirmatory methods. Springer Online Journal Archives 1860-2002 Vermylen, J. oth Arnout, J. oth in Clinical rheumatology 1982 9(1990) vom: Jan., Seite 45-50 (DE-627)NLEJ188995013 (DE-600)1480901-1 1434-9949 nnns volume:9 year:1990 month:01 pages:45-50 extent:6 http://dx.doi.org/10.1007/BF02205551 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 9 1990 1 45-50 6 |
allfields_unstemmed |
(DE-627)NLEJ206856970 DE-627 ger DE-627 rakwb eng Influence of the lupus anticoagulant on clotting tests 1990 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Conclusion The firm diagnosis of a lupus anticoagulant needs the use of multiple test systems including a sensitive screening test, a test to demonstrate that the clotting time prolongation is due to an anticoagulant and a confirmatory test proving the antiphospholipid nature of the anticoagulant. A large variety of test systems are currently available for the detection of a lupus anticoagulant. There is a need for further data on the relative sensitivity and specificity of both screening tests and confirmatory methods. Springer Online Journal Archives 1860-2002 Vermylen, J. oth Arnout, J. oth in Clinical rheumatology 1982 9(1990) vom: Jan., Seite 45-50 (DE-627)NLEJ188995013 (DE-600)1480901-1 1434-9949 nnns volume:9 year:1990 month:01 pages:45-50 extent:6 http://dx.doi.org/10.1007/BF02205551 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 9 1990 1 45-50 6 |
allfieldsGer |
(DE-627)NLEJ206856970 DE-627 ger DE-627 rakwb eng Influence of the lupus anticoagulant on clotting tests 1990 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Conclusion The firm diagnosis of a lupus anticoagulant needs the use of multiple test systems including a sensitive screening test, a test to demonstrate that the clotting time prolongation is due to an anticoagulant and a confirmatory test proving the antiphospholipid nature of the anticoagulant. A large variety of test systems are currently available for the detection of a lupus anticoagulant. There is a need for further data on the relative sensitivity and specificity of both screening tests and confirmatory methods. Springer Online Journal Archives 1860-2002 Vermylen, J. oth Arnout, J. oth in Clinical rheumatology 1982 9(1990) vom: Jan., Seite 45-50 (DE-627)NLEJ188995013 (DE-600)1480901-1 1434-9949 nnns volume:9 year:1990 month:01 pages:45-50 extent:6 http://dx.doi.org/10.1007/BF02205551 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 9 1990 1 45-50 6 |
allfieldsSound |
(DE-627)NLEJ206856970 DE-627 ger DE-627 rakwb eng Influence of the lupus anticoagulant on clotting tests 1990 6 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Conclusion The firm diagnosis of a lupus anticoagulant needs the use of multiple test systems including a sensitive screening test, a test to demonstrate that the clotting time prolongation is due to an anticoagulant and a confirmatory test proving the antiphospholipid nature of the anticoagulant. A large variety of test systems are currently available for the detection of a lupus anticoagulant. There is a need for further data on the relative sensitivity and specificity of both screening tests and confirmatory methods. Springer Online Journal Archives 1860-2002 Vermylen, J. oth Arnout, J. oth in Clinical rheumatology 1982 9(1990) vom: Jan., Seite 45-50 (DE-627)NLEJ188995013 (DE-600)1480901-1 1434-9949 nnns volume:9 year:1990 month:01 pages:45-50 extent:6 http://dx.doi.org/10.1007/BF02205551 GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE AR 9 1990 1 45-50 6 |
language |
English |
source |
in Clinical rheumatology 9(1990) vom: Jan., Seite 45-50 volume:9 year:1990 month:01 pages:45-50 extent:6 |
sourceStr |
in Clinical rheumatology 9(1990) vom: Jan., Seite 45-50 volume:9 year:1990 month:01 pages:45-50 extent:6 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
isfreeaccess_bool |
false |
container_title |
Clinical rheumatology |
authorswithroles_txt_mv |
Vermylen, J. @@oth@@ Arnout, J. @@oth@@ |
publishDateDaySort_date |
1990-01-01T00:00:00Z |
hierarchy_top_id |
NLEJ188995013 |
id |
NLEJ206856970 |
language_de |
englisch |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ206856970</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210706212934.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070528s1990 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ206856970</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Influence of the lupus anticoagulant on clotting tests</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1990</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Conclusion The firm diagnosis of a lupus anticoagulant needs the use of multiple test systems including a sensitive screening test, a test to demonstrate that the clotting time prolongation is due to an anticoagulant and a confirmatory test proving the antiphospholipid nature of the anticoagulant. A large variety of test systems are currently available for the detection of a lupus anticoagulant. There is a need for further data on the relative sensitivity and specificity of both screening tests and confirmatory methods.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Springer Online Journal Archives 1860-2002</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vermylen, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arnout, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Clinical rheumatology</subfield><subfield code="d">1982</subfield><subfield code="g">9(1990) vom: Jan., Seite 45-50</subfield><subfield code="w">(DE-627)NLEJ188995013</subfield><subfield code="w">(DE-600)1480901-1</subfield><subfield code="x">1434-9949</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:1990</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:45-50</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1007/BF02205551</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-SOJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">1990</subfield><subfield code="c">1</subfield><subfield code="h">45-50</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ206856970</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210706212934.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">070528s1990 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ206856970</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Influence of the lupus anticoagulant on clotting tests</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1990</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">6</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Conclusion The firm diagnosis of a lupus anticoagulant needs the use of multiple test systems including a sensitive screening test, a test to demonstrate that the clotting time prolongation is due to an anticoagulant and a confirmatory test proving the antiphospholipid nature of the anticoagulant. A large variety of test systems are currently available for the detection of a lupus anticoagulant. There is a need for further data on the relative sensitivity and specificity of both screening tests and confirmatory methods.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Springer Online Journal Archives 1860-2002</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vermylen, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arnout, J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">in</subfield><subfield code="t">Clinical rheumatology</subfield><subfield code="d">1982</subfield><subfield code="g">9(1990) vom: Jan., Seite 45-50</subfield><subfield code="w">(DE-627)NLEJ188995013</subfield><subfield code="w">(DE-600)1480901-1</subfield><subfield code="x">1434-9949</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:9</subfield><subfield code="g">year:1990</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:45-50</subfield><subfield code="g">extent:6</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1007/BF02205551</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-SOJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">9</subfield><subfield code="j">1990</subfield><subfield code="c">1</subfield><subfield code="h">45-50</subfield><subfield code="g">6</subfield></datafield></record></collection>
|
series2 |
Springer Online Journal Archives 1860-2002 |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ188995013 |
format |
electronic Article |
delete_txt_mv |
keep |
collection |
NL |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
1434-9949 |
topic_title |
Influence of the lupus anticoagulant on clotting tests |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
j v jv j a ja |
hierarchy_parent_title |
Clinical rheumatology |
hierarchy_parent_id |
NLEJ188995013 |
hierarchy_top_title |
Clinical rheumatology |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)NLEJ188995013 (DE-600)1480901-1 |
title |
Influence of the lupus anticoagulant on clotting tests |
spellingShingle |
Influence of the lupus anticoagulant on clotting tests |
ctrlnum |
(DE-627)NLEJ206856970 |
title_full |
Influence of the lupus anticoagulant on clotting tests |
journal |
Clinical rheumatology |
journalStr |
Clinical rheumatology |
lang_code |
eng |
isOA_bool |
false |
recordtype |
marc |
publishDateSort |
1990 |
contenttype_str_mv |
zzz |
container_start_page |
45 |
container_volume |
9 |
physical |
6 |
format_se |
Elektronische Aufsätze |
title_sort |
influence of the lupus anticoagulant on clotting tests |
title_auth |
Influence of the lupus anticoagulant on clotting tests |
abstract |
Conclusion The firm diagnosis of a lupus anticoagulant needs the use of multiple test systems including a sensitive screening test, a test to demonstrate that the clotting time prolongation is due to an anticoagulant and a confirmatory test proving the antiphospholipid nature of the anticoagulant. A large variety of test systems are currently available for the detection of a lupus anticoagulant. There is a need for further data on the relative sensitivity and specificity of both screening tests and confirmatory methods. |
abstractGer |
Conclusion The firm diagnosis of a lupus anticoagulant needs the use of multiple test systems including a sensitive screening test, a test to demonstrate that the clotting time prolongation is due to an anticoagulant and a confirmatory test proving the antiphospholipid nature of the anticoagulant. A large variety of test systems are currently available for the detection of a lupus anticoagulant. There is a need for further data on the relative sensitivity and specificity of both screening tests and confirmatory methods. |
abstract_unstemmed |
Conclusion The firm diagnosis of a lupus anticoagulant needs the use of multiple test systems including a sensitive screening test, a test to demonstrate that the clotting time prolongation is due to an anticoagulant and a confirmatory test proving the antiphospholipid nature of the anticoagulant. A large variety of test systems are currently available for the detection of a lupus anticoagulant. There is a need for further data on the relative sensitivity and specificity of both screening tests and confirmatory methods. |
collection_details |
GBV_USEFLAG_U ZDB-1-SOJ GBV_NL_ARTICLE |
title_short |
Influence of the lupus anticoagulant on clotting tests |
url |
http://dx.doi.org/10.1007/BF02205551 |
remote_bool |
true |
author2 |
Vermylen, J. Arnout, J. |
author2Str |
Vermylen, J. Arnout, J. |
ppnlink |
NLEJ188995013 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth |
up_date |
2024-07-06T08:05:00.540Z |
_version_ |
1803816115153928192 |
score |
7.4007626 |